SCHEMBL12759079

SCHEMBL12759079

CC(c1ccc(S(=O)(=O)O)cc1)P(C1CCCCC1)C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.38
CHRM2 P08172 7/20 0.38
CHRM1 P11229 7/20 0.38
MCOLN3 Q8TDD5 1/20 0.36
LMNA P02545 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP1A2 P05177 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
TSHR P16473 2/20 0.34
ALDH1A1 P00352 1/20 0.34
NT5E P21589 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12759082 0.78 ALDH1A1 (0.35) LMNAHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL12759094 0.75 GAA (0.46) MCOLN3LMNACYP2C19ALDH1A1HTT
SCHEMBL8587132 0.75 LMNA (0.46) CHRM2CHRM1MCOLN3LMNAHSD17B10
SCHEMBL3008249 0.73 ALDH1A1 (0.49) EPHX2LMNAHSD17B10TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL27547678 0.71 LMNA (0.41) EPHX2CHRM2CHRM1LMNAHSD17B10
SCHEMBL20853608 0.69 ALDH1A1 (0.52) LMNAHSD17B10MAPK1TSHRALDH1A1
SCHEMBL11591763 0.68 LMNA (0.52) MCOLN3LMNAHSD17B10MAPK1TSHR
SCHEMBL29618 0.68 ALDH1A1 (0.56) MCOLN3LMNATSHRALDH1A1NT5E
SCHEMBL1500503 0.68 LMNA (0.49) LMNAHSD17B10MAPK1TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL340601 0.67 ALDH1A1 (0.54) MCOLN3LMNATSHRALDH1A1NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466306-B2 Sulfonated organophosphine compounds and use in hydroformylation processes DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-18 US disclosed
US-8466306-B2 Sulfonated organophosphine compounds and use in hydroformylation processes DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-18 US disclosed
US-20110054203-A1 SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES DOW GLOBAL TECHNOLOGIES INC. (US) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054203-A1 SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES ORMDL3, IP6K3, ALK EPHX2 2184/4885CHRM2 224/4885CHRM1 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.